Trials / Conditions / Adenocarcinoma of the Esophagogastric Junction

Adenocarcinoma of the Esophagogastric Junction

9 registered clinical trials studyying Adenocarcinoma of the Esophagogastric Junction — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled Study NCT07095699	Fudan University	N/A
Active Not Recruiting	A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Eso NCT06681298	xiaohua li	Phase 2
Completed	Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort St NCT05419349	Fujian Medical University Union Hospital	—
Unknown	Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG NCT04062656	University Hospital, Essen	Phase 2
Unknown	The Application of Fluorescence Laparoscopy in the Treatment of Adenocarcinoma of the Esophagogastric Junction NCT03647540	Dong Yang	N/A
Active Not Recruiting	Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esoph NCT02509286	University Hospital Schleswig-Holstein	Phase 3
Completed	Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction NCT02287129	Technical University of Munich	Phase 2
Completed	Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Aden NCT00849615	Krankenhaus Nordwest	Phase 2
Completed	Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagu NCT00737373	Krankenhaus Nordwest	Phase 2